SELECTED IMPORTANT SAFETY INFORMATION
  • Some people who have taken medicine like ATRIPLA have developed build up of lactic acid in the blood, which can be a serious medical emergency that can lead to death.

  • Some people who have taken medicines like ATRIPLA have developed

    serious liver problems, with liver enlargement and fat in the liver, which can lead to death.

  • If you also have hepatitis B virus (HBV) infection and you stop taking ATRIPLA, your hepatitis may suddenly
    get worse.     ATRIPLA is not approved for the treatment of HBV.
Search:
information for healthcare professionals
information for healthcare professionals
Please click here for more information about these warnings, including signs and symptoms, and other Important Safety Information.
About ATRIPLA
Starting ATRIPLA
Paying for your Meds
HIV Basics
Peer Advocate Network
Important Safety Information

Education and Support

There are many HIV information sources and patient groups that can help you keep informed and answer any questions you may have about HIV. The following list contains contact information for some of these organizations.

HIV/AIDS: General Web Sites

AIDS Education Global Information System (AEGiS):
1-949-248-5843
www.aegis.com

AIDSinfo:
1-800-HIV-0440 (1-800-448-0440)
www.aidsinfo.nih.gov

AIDS InfoNet:
www.aidsinfonet.org

AIDSmeds.com:
www.aidsmeds.com

AIDS Treatment Data Network:
1-800-734-7104, ext. 22
www.atdn.org
www.atdn.org/access/index.html

American Foundation for AIDS Research (amfAR):
1-800-39-amfAR (1-800-392-6327)
www.amfar.org

Balm in Gilead:
1-888-225-6243
www.balmingilead.org

Black AIDS Institute:
1-213-353-3610
www.blackaids.org

Centers for Disease Control and Prevention (CDC):
1-800-CDC-INFO (1-800-232-4636)
www.cdc.gov/hiv

CDC National Prevention Information Network:
1-800-458-5231
www.cdcnpin.org

Gay Men's Health Crisis (GMHC):
1-212-367-1000
www.gmhc.org

National Association of People with AIDS (NAPWA):
1-866-846-9366
www.napwa.org

National AIDS Treatment Advocacy Project (NATAP) – HIV:
1-888-26-NATAP (1-888-266-2827)
www.natap.org
www.natap.org/hiv.htm

National Library of Medicine – HIV/AIDS:
1-888-FINDNLM (1-888-346-3656)
http://sis.nlm.nih.gov/hiv.html

National Minority AIDS Council:
1-202-483-6622
www.nmac.org

Project Inform:
1-800-822-7422
www.projectinform.org

The Body:
www.thebody.com


HIV/AIDS: Spanish Language

AIDS InfoNet – Español:
www.aidsinfonet.org/?newLang=es

Centers for Disease Control and Prevention – Español:
1-800-CDC-INFO (1-800-232-4636)
www.cdc.gov/hiv/spanish/default.htm

Latino Commission on AIDS:
1-212-675-3288
www.latinoaids.org

Project Inform en Español:
1-800-822-7422
www.projectinform.org/info/index_sp.shtml

The Body en Español:
www.thebody.com/espanol.shtml


HIV/AIDS: Women

The Body – HIV Treatment & Women:
www.thebody.com/index/treat/women.html

This list of third-party resources is provided as a convenience to you. Bristol-Myers Squibb & Gilead Sciences, LLC expressly disclaims any and all liability and responsibility for these resources.

ATRIPLA does not cure HIV-1 infection or AIDS and you may continue to experience illnesses associated with HIV-1 infection, including opportunistic infections.

See your healthcare provider regularly while taking ATRIPLA.

Please click here for Important Safety Information, including information on buildup of lactic acid in the blood, serious liver problems, and sudden worsening of hepatitis B virus.
Patient Product Information
Full Prescribing Information
Sign up to learn more
Please send me information and updates.
ASO Finder
Find an HIV/AIDS Service Organization near you.
Distance to search:
Enter your ZIP code:

  • You may be more likely to get lactic acidosis or liver problems if you are female, very overweight (obese), or have been taking nucleoside analog-containing medicines, like ATRIPLA, for a long time.
  • Women should not become pregnant while taking ATRIPLA and for 12 weeks after stopping ATRIPLA. Women with HIV should not breastfeed because they can pass HIV or may pass ATRIPLA through their milk to the baby.

Atripla

Click here for ATRIPLA Full Prescribing Information.

(c) 2012 Bristol-Myers Squibb Company.

ATRIPLA and ATRIPLA Peer Advocate Network are registered trademarks of Bristol-Myers Squibb & Gilead Sciences, LLC. SUSTIVA is a registered trademark of Bristol-Myers Squibb Company. COMPLERA, EMTRIVA, GILEAD, GSI, HEPSERA, TRUVADA, and VIREAD are trademarks of Gilead Sciences, Inc., or its related companies. All other trademarks referenced herein are the property of their respective owners.

Patient models are used on this Web site. The information on this site is intended for residents of the United States who are 18 years of age or older. The content of this site is protected under applicable copyright and trademarks law.

This site may contain, from time to time, information related to various health, medical and fitness conditions, and their treatment. Such information is not meant to be a substitute for the advice provided by a physician or other medical professional. You should not use the information contained herein for diagnosing a health or fitness problem or disease. You should always consult a physician and/or a healthcare provider.

Your use of this information is subject to the terms and conditions of our Terms of Use and Privacy Policy.

697US12WA04601  07/12
How ATRIPLA Works
Side Effects
Questions for Your Doctor
How to Take ATRIPLA
Other Medications
CoPay Assistance Program
Goals of HIV Treatment
Treatment Options
HIV FAQs
Healthy Living
Education and Support